Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity

Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity

Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy bindin...

Bibliográfalaš dieđut
Váldodahkkit:	Han, J-H, Cho, J-S, Ong, JJY, Park, J-H, Nyunt, MH, Sutanto, E, Trimarsanto, H, Petros, B, Aseffa, A, Getachew, S, Sriprawat, K, Anstey, NM, Grigg, MJ, Barber, BE, William, T, Qi, G, Liu, Y, Pearson, RD, Auburn, S, Price, RN, Nosten, F, Rénia, L, Russell, B, Han, E-T
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Public Library of Science 2020

Geahča maid

Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity.
Dahkki: Jin-Hee Han, et al.
Almmustuhtton: (2020-07-01)

Genomic analysis of plasmodium vivax in southern Ethiopia reveals selective pressures in multiple parasite mechanisms
Dahkki: Auburn, S, et al.
Almmustuhtton: (2019)

Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics
Dahkki: Auburn, S, et al.
Almmustuhtton: (2018)

Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
Dahkki: Park, J-H, et al.
Almmustuhtton: (2022)

Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia
Dahkki: Kebede, AM, et al.
Almmustuhtton: (2023)

Variation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern Ethiopia.
Dahkki: Sisay Getachew, et al.
Almmustuhtton: (2015-01-01)

Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
Dahkki: Getachew, S, et al.
Almmustuhtton: (2015)

A molecular barcode and online tool to identify and map imported infection with Plasmodium vivax
Dahkki: Trimarsanto, H, et al.
Almmustuhtton: (2019)

Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics
Dahkki: Sarah Auburn, et al.
Almmustuhtton: (2018-07-01)

Plasmodium vivax susceptibility to ferroquine.
Dahkki: Leimanis, M, et al.
Almmustuhtton: (2010)

Efficacy of artesunate-mefloquine for chloroquine-resistant Plasmodium vivax malaria in Malaysia: An open-label, randomized, controlled trial.
Dahkki: Grigg, M, et al.
Almmustuhtton: (2016)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
Dahkki: Oyong, DA, et al.
Almmustuhtton: (2018)

Further evidence of increasing diversity of Plasmodium vivax in the Republic of Korea in recent years
Dahkki: Kim, J, et al.
Almmustuhtton: (2016)

Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity.
Dahkki: Ji-Hoon Park, et al.
Almmustuhtton: (2022-06-01)

Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia
Dahkki: Alebachew Messele Kebede, et al.
Almmustuhtton: (2023-11-01)

Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia
Dahkki: Abdullah, N, et al.
Almmustuhtton: (2013)

A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes
Dahkki: Auburn, S, et al.
Almmustuhtton: (2016)

Whole genome sequencing of Plasmodium vivax isolates reveals frequent sequence and structural polymorphisms in erythrocyte binding genes.
Dahkki: Anthony Ford, et al.
Almmustuhtton: (2020-10-01)

No association between the Plasmodium vivax crt-o MS334 or In9pvcrt polymorphisms and chloroquine failure in a pre-elimination clinical cohort from Malaysia with a large clonal expansion
Dahkki: Rumaseb, A, et al.
Almmustuhtton: (2023)

Genetic diversity and population structure of Plasmodium vivax in Central China.
Dahkki: Liu, Y, et al.
Almmustuhtton: (2014)

A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
Dahkki: Trimarsanto, H, et al.
Almmustuhtton: (2022)

Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture
Dahkki: Borlon, C, et al.
Almmustuhtton: (2012)

Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture.
Dahkki: Borlon, C, et al.
Almmustuhtton: (2012)

VivaxGEN: An open access platform for comparative analysis of short tandem repeat genotyping data in Plasmodium vivax Populations.
Dahkki: Trimarsanto, H, et al.
Almmustuhtton: (2017)

Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax.
Dahkki: Imwong, M, et al.
Almmustuhtton: (2011)

Genomics of Plasmodium vivax in Colombia reveals evidence of local bottle-necking and inter-country connectivity in the Americas
Dahkki: Sutanto, E, et al.
Almmustuhtton: (2023)

Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood.
Dahkki: Sriprawat, K, et al.
Almmustuhtton: (2009)

Genomic analysis reveals a common breakpoint in amplifications of the Plasmodium vivax multidrug resistance 1 locus in Thailand
Dahkki: Auburn, S, et al.
Almmustuhtton: (2016)

Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.
Dahkki: Suwanarusk, R, et al.
Almmustuhtton: (2015)

Characteristics of Plasmodium vivax-infected erythrocyte rosettes.
Dahkki: Chotivanich, K, et al.
Almmustuhtton: (1998)

Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria
Dahkki: Barber, B, et al.
Almmustuhtton: (2015)

Artemisinin combination therapy for vivax malaria.
Dahkki: Douglas, N, et al.
Almmustuhtton: (2010)

Anti-phosphatidylserine IGM and IGG antibodies are increased in falciparum and vivax malaria and correlate with anaemia
Dahkki: Barber, B, et al.
Almmustuhtton: (2017)

Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencing
Dahkki: Auburn, S, et al.
Almmustuhtton: (2013)

Limitations of microscopy to differentiate <it>Plasmodium</it> species in a region co-endemic for <it>Plasmodium falciparum</it>, <it>Plasmodium vivax</it> and <it>Plasmodium knowlesi</it>
Dahkki: Barber Bridget E, et al.
Almmustuhtton: (2013-01-01)

Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes.
Dahkki: Laurin J Kasehagen, et al.
Almmustuhtton: (2007-03-01)

Rosetting responses of Plasmodium-infected erythrocytes to antimalarials
Dahkki: Lee, W-C, et al.
Almmustuhtton: (2022)

Characterisation of Plasmodium vivax lactate dehydrogenase dynamics in P. vivax infections
Dahkki: Pengxing Cao, et al.
Almmustuhtton: (2024-03-01)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
Dahkki: Pava, Z, et al.
Almmustuhtton: (2020)

Endothelial glycocalyx degradation and disease severity in Plasmodium vivax and Plasmodium knowlesi malaria
Dahkki: Barber, Bridget E., et al.
Almmustuhtton: (2021)